Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on October 26, 2026

Oct. 26, 2026

Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia

Indeterminate GlobeNewswire

Oct. 26, 2026

Xpanner Launches X1 Piling R6, Bringing One-Touch Automated Pile Driving to Solar and BESS Construction

Indeterminate GlobeNewswire

Oct. 26, 2026

Law Enforcement Finds “Brain Games” Save Lives

Indeterminate GlobeNewswire

Oct. 26, 2026

Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire

Oct. 26, 2026

Partner1 Renews WBENC Women's Business Enterprise and Women-Owned Small Business Certifications

Indeterminate GlobeNewswire

Oct. 26, 2026

Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening

Indeterminate GlobeNewswire

Oct. 26, 2026

Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC

Indeterminate GlobeNewswire

Oct. 26, 2026

Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Oct. 26, 2026

Dot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directors

Indeterminate GlobeNewswire

Oct. 26, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Indeterminate GlobeNewswire

Oct. 26, 2026

Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator

Indeterminate GlobeNewswire

Oct. 26, 2026

Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness

Indeterminate GlobeNewswire

Oct. 26, 2026

Xtract One Technologies to Present at Planet MicroCap Toronto 2026 Powered by MicroCapClub

Indeterminate GlobeNewswire

Oct. 26, 2026

Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy

Indeterminate GlobeNewswire